Obesity is a leading risk factor for cancer. However, understanding the crosstalk between adipocytes and tumor cells in vivo, independently of dietary contributions, is a major gap in the field. Here we used a prostate cancer (PCa) mouse model in which the signaling adaptor p62/Sqstm1 is selectively inactivated in adipocytes. p62 loss in adipocytes results in increased osteopontin secretion, which mediates tumor fatty acid oxidation and invasion, leading to aggressive metastatic PCa in vivo. Furthermore, p62 deficiency triggers in adipocytes a general shutdown of energy-utilizing pathways through mTORC1 inhibition, which supports nutrient availability for cancer cells. This reveals a central role of adipocyte's p62 in the symbiotic adipose tissue-tumor collaboration that enables cancer metabolic fitness.
In Brief
Huang et al. show in a prostate cancer mouse model that p62 loss in adipocytes leads to aggressive disease by increasing osteopontin secretion, which mediates tumor fatty acid oxidation and invasion. P62 deficiency also represses energyconsuming pathways in adipocytes, increasing nutrient availability for tumors.
INTRODUCTION
Prostate cancer (PCa) is the second leading cause of cancer death among men in the United States (Brawley, 2012) . High prevalence and mortality as well as the long period of time to tumor development are major challenges for PCa research. Obesity is another growing epidemic in Western societies and in developing nations and represents one of the greatest threats to global human health (Finkelstein et al., 2005) . Recent epidemiological studies have pointed to an association between obesity and increased risk of cancer, not only in its incidence but also its progression (Calle and Kaaks, 2004) . In fact, obesity is the second leading preventable cause of cancer (Wolin et al., 2010) , and given the current obesity epidemic and an aging population, there is increasing concern about the role of obesity in cancer.
There is emerging support for a positive association between obesity and increased risk of PCa, with stronger links to more aggressive fatal disease (Wright et al., 2007) . Thus, obesity has been found to be a highly significant risk factor for PCa progression and aggressiveness (Freedland and Platz, 2007; MacInnis and English, 2006) , with several studies showing more adverse pathological features and higher risk for biochemical recurrence in obese men undergoing radical prostatectomy (Cao and Ma, 2011; Rodriguez et al., 2001 ). Severely obese men had a 34% higher risk of dying of PCa relative to men of normal weight (Calle et al., 2003) . In addition, obesity has also been associated with
Significance
Obesity is a risk factor in cancer and a fundamental health problem due to the current obesity epidemic. However, the precise crosstalk between adipose tissue and tumor cells remains poorly understood. The adaptor p62 was reported to play an important role in cancers, in both the tumor epithelia and stromal fibroblasts. However, whether it also controls the interactions between tumor cells and adipocytes was unknown, but is an important question for the identification of key metabolic vulnerabilities in this process. Here we establish the role of p62 as a tumor suppressor due to its ability to repress the protumorigenic effects of increased adiposity. Therefore, adipocyte's p62-derived pathways emerge as potential therapeutic targets in the control of tumor-adipose tissue homeostasis. (legend continued on next page) increased risk of progression to castration-resistant PCa, the development of metastases, and PCa-specific mortality (Keto et al., 2012) . Likewise, higher visceral fat has been shown to be associated with an increased risk for PCa (Finley et al., 2009; von Hafe et al., 2004) . However, although epidemiological studies support a role for obesity and weight gain as important risk factors for poor outcome in men diagnosed with PCa, there are still many gaps in our knowledge that need to be investigated to understand the underlying molecular mechanisms of this phenomenon.
Increased adiposity might affect tumorigenesis by providing an excess supply of nutrients and increased levels of pro-inflammatory cytokines, which can be major drivers in different types of cancers, including PCa (De Marzo et al., 2007; Ouchi et al., 2011; Sutcliffe and Platz, 2007) . Many studies have addressed the different metabolic wiring of cancer cells under defined cell culture conditions, but very few have considered this from a holistic point of view. In this regard, total body inactivation of the signaling adaptor and autophagy substrate p62 (encoded by the Sqstm1 gene) results in mature-onset obesity due to increased adiposity and reduced energy expenditure (Rodriguez et al., 2006) . Also, the selective genetic inactivation of p62 in adipocytes recapitulates the increased adiposity of total knockout (KO) mice, demonstrating that p62 plays critical roles in repressing adipose tissue expansion (Muller et al., 2013) . Importantly, this phenotype is not due to hypothetical differences in locomotor activity or food intake (Rodriguez et al., 2006) . This adipocyte-specific p62 KO model is particularly relevant because most studies addressing the role of obesity in cancer relied on models in which mice are fed a high-fat diet or harbor the genetic inactivation of leptin (Park et al., 2010; Venkateswaran et al., 2007) . Both approaches have pleiotropic implications, which complicate the interpretation of the results and do not allow the study of the specific crosstalk between adipocytes and tumor tissue independently of dietary contributions. Here we have addressed this important question by generating mouse lines in which p62 is selectively inactivated, or not, in the adipose tissue in the TRAMP + mouse model of PCa. This cancer model system is one of the most widely used to investigate prostate tumorigenesis in vivo (Greenberg et al., 1995) . Using this in vivo model and co-culture experiments we investigated the pathways and signaling cascades that govern the crosstalk between adipose tissue and PCa cells, and the role of p62 in that process.
RESULTS

Increased Adiposity Promotes PCa Progression and Metastasis
To establish the molecular mechanisms leading to the crosstalk between the adipose tissue and the tumor in PCa, we sought to establish an endogenous genetic mouse model system in which to carry out cause and effect mechanistic in vivo studies independent of food intake and diet. Previously we have identified p62 as a key player in obesity-induced inflammation using an adipocyte-specific cre system (aP2-Cre). Adipocyte-specific deletion of p62 results in obesity, glucose intolerance, and insulin resistance (Muller et al., 2013) . Therefore, we next bred these mice (p62 Adipo ) with the well-established TRAMP model of PCa to generate TRAMP + /p62 Adipo and their corresponding TRAMP + / wild-type (WT) controls. In this model, the oncoprotein, SV40 T antigen (TAg), is expressed under the transcriptional control of the rat probasin promoter, which restricts TAg expression to epithelial cells within the prostate (Greenberg et al., 1995) . TRAMP + /p62
Adipo mice lack p62 selectively in the adipocytes and develop PCa. To demonstrate the selective deletion of p62 in adipocytes and the lack of hypothetical off-target effects of the aP2-Cre system in macrophages, we doubly stained epididymal WAT (eWAT) from p62 Adipo mice for p62 and F4/80, and confirmed the exclusive deletion of p62 in adipocytes (Figure S1A) . Also, the macrophages isolated from p62
Adipo WAT maintained levels of Sqstm1 transcripts (coding for p62) similar to those from WT mice ( Figure S1B ). Furthermore, p62 was not deleted in macrophages in eWAT or periprostatic WAT (ppWAT) from TRAMP + /p62 Adipo mice (Figures S1C and S1D).
Although disease-free survival curves (Kaplan-Meier plots) show no differences between both mouse lines, probably due to the large volume of the primary tumor in both groups (not shown), genitourinary (GU) weight was significantly increased in TRAMP + /p62
Adipo mice compared with the control group ( Figure 1A ). Most importantly, we found that TRAMP + /p62
Adipo mice developed a more aggressive PCa phenotype with higher incidence of adenocarcinoma and neuroendocrine tumors than TRAMP + /WT controls ( Figure 1B ). Prostate tumors from TRAMP + /p62
Adipo mice displayed increased proliferation, as detected by Ki67 staining ( Figure 1C ), without differences in apoptosis, as detected by cleaved caspase-3 staining (Figure 1D ). TRAMP + /p62 Adipo mice also had higher metastasis incidence in liver and lung compared with the control group ( Figures  1E-1H ). We also found metastasis in kidney, white (WAT), and brown (BAT) adipose tissues in TRAMP + /p62 Adipo mice but these were not detected in TRAMP + /WT mice ( Figures 1F-1H ). Therefore, the selective loss of p62 in the adipose tissue drives tumorigenesis and invasiveness in PCa, which demonstrates, using physiologically relevant genetic in vivo models, the existence of a molecular link between the adipose tissue and the tumor. (Muller et al., 2013) . However, in a TRAMP + background, no differences were observed in any of these parameters between p62
Adipo and p62 WT mice (Figures 2A-2E ). Liver TG and total cholesterol (TC) levels ( Figure 2E ), and oil red O staining (Figures 2F and 2G) in liver, also revealed no significant differences in lipid (F and G) Distribution of metastasis sites (F; two-way ANOVA, **p < 0.01) and their corresponding percentages of total incidence (G).
(H) H&E staining of prostates and metastases in different tissues of the indicated genotypes at 37 weeks of age. eWAT, epididymal WAT; ppWAT, periprostatic WAT; TU, tumors; M, metastases. Scale bars, 100 mm.
Results are presented as mean ± SEM (A, C, D). See also Figure S1 .
accumulation between both genotypes, whereas p62 Adipo mice developed fatty liver in the TRAMP-negative background . Moreover, the size of adipocytes that was larger in non-tumor-bearing p62 Adipo mice did not differ between both genotypes in TRAMP + mice ( Figures 2H and 2I ). These results indicate that the selective loss of p62 in adipocytes results in increased adiposity but this is blunted by the presence of the tumor, which is more aggressive than in p62-proficient mice.
To establish the whole-body metabolic impact of PCa in the context of p62 deficiency on the adipose tissue, we performed a full metabolic characterization of these mice by using an automated indirect calorimetry system (CLAMS). The analysis of all the metabolic parameters measured, including food intake, drinking, horizontal and vertical activity, volume of O 2 (VO 2 ), volume of CO 2 (VCO 2 ), and respiratory exchange ratio, did not show significant changes between the TRAMP + /p62 Adipo mice group and the control TRAMP + mice ( Figures S2A-S2H ). Consistently, energy expenditure did not differ between groups after adjusting for body weight, lean mass, or fat mass according to analysis of covariance (ANCOVA) ( Figure S2I ). It should be noted that in our previous report of the p62 Adipo mice we showed that they have a reduced metabolic rate caused by impaired non-shivering thermogenesis (Muller et al., 2013 (legend continued on next page) be consistent with the increased energy expenditure and activation of thermogenesis that have been proposed as causative of adipose cancer-associated cachexia (Kir and Spiegelman, 2016; Petruzzelli et al., 2014 Figure 3B ).
qRT-PCR analysis of inguinal WAT (iWAT) and eWAT confirmed the significant inhibition of key adipogenic (Figures 3C and S3A) and mitochondrial genes ( Figures 3D and S3B ) under these conditions. Interestingly, these changes in adipose tissue between WT and p62 Adipo mice were not observed in the absence of TRAMP tumors ( Figures 3C, 3D , S3A, and S3B).
Previous reports have shown that tumors promote energy expenditure in fat by inducing ''adipocyte browning'' (Kir and Spiegelman, 2016; Petruzzelli et al., 2014) . As expected, Ucp1 levels, a hallmark of that process, was dramatically upregulated, along with other mitochondrial genes, in TRAMP + /WT adipose tissues compared with TRAMP À controls ( Figures 3D and   S3B ). More importantly, the expression of these genes was not upregulated in p62-deficient adipose tissues (Figures 3D and S3B) . To test whether these transcriptional changes affect mitochondrial respiration, we measured oxygen consumption rate (OCR) in WAT explants from the four genotypes. Consistently, respiration was upregulated by PCa tumors in TRAMP + /WT but not in TRAMP + /p62 Adipo mice ( Figure 3E ). Interestingly, the role of p62 in the control of mitochondrial respiration was also observed in differentiated p62 KO adipocytes when compared with WT controls ( Figure 3F ). These results demonstrate that the induction of adipose tissue browning by PCa requires p62. Therefore, p62 deficiency in adipocytes prevents the induction of adipose tissue energy utilization and wasting by the TRAMP tumors.
Of mechanistic relevance, further interrogation of the WAT transcriptome revealed that a signature corresponding to mTORC1 signaling was negatively correlated in the WAT of TRAMP + /p62 Adipo mice, compared with that of TRAMP + /WT ( Figure 3G ). Likewise, a ''WAT Rapamycin DN'' signature was negatively correlated, whereas a ''WAT Rapamycin UP'' signature was enriched, in TRAMP + /p62 Adipo WAT as compared with TRAMP + /WT WAT ( Figure S3C ). These WAT signatures were obtained from mice treated with rapamycin, a well-established inhibitor of mammalian target of rapamycin complex 1 (mTORC1). These results further support the positive correlation between p62 expression and mTORC1 activation in WAT. Of human relevance, GSEA showed that the transcriptional level of SQSTM1 positively correlated with mTORC1 signaling enrichment in human WAT ( Figures 3H and S3D ). The p62 regulation of mTORC1 was confirmed by immunoblotting, which showed a dramatic inhibition of S6 and 4EBP1 phosphorylation, two bona fide downstream targets of mTORC1 ( Figure 3I ). These are important observations because mTORC1 is a well-recognized regulator of lipogenesis via SREBP1 (Li et al., 2010) . Indeed, immunoblotting analysis of the same extracts confirmed reduced levels of FASN in p62-deficient adipose tissue (Figure 3I) . Together, these results demonstrate that the reduced activity of mTORC1 in the adipose tissue of p62 Adipo mice serves to prevent the activation of energy-consuming pathways in the adipose tissue of PCa-bearing mice, which results in saving nutrients for the benefit of the tumor. Adipo tumors revealed a marked enrichment of gene sets associated with FA metabolism, FA b-oxidation, and peroxisome proliferator-activated receptor a (PPARa) activation ( Figure 4A and Table S1 ). There was also a robust increase in FA oxidation genes ( Figures 4B and 4C ) and, of special relevance, we found increased Cpt1a transcript levels, which was confirmed by immunoblotting analysis ( Figure 4D ). Changes in Cpt1a are particularly interesting given the recent description of a critical role of FA oxidation in several types of cancers including PCa (Schlaepfer et al., 2014) . Our finding of inverse effects in adipose tissue and PCa tumors in terms of metabolic and energy (H) GSEA plot of ''mTORC1_SIGNALING'' signature positively correlated to SQSTM1 transcript levels in human normal WAT (n = 26, GEO: GSE25402) using H MSigDB collection. (I) Immunoblots and quantification of mTORC1 downstream targets in ppWAT of TRAMP + /p62 Adipo and TRAMP + /WT mice (n = 4).
Results are presented as mean ± SEM (C-F and I). Student's t test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). See also Figure S3 . (legend continued on next page) utilization triggered by adipocyte-specific deficiency of p62 would explain why the TRAMP tumors can metabolically afford higher degrees of tumorigenesis in p62 Adipo mice in comparison to WT mice. Interestingly, this metabolic rewiring is accompanied by the induction of an epithelial-mesenchymal transition (EMT) signature (Figures 4E and 4F) , which is consistent with the increased incidence of metastasis in TRAMP + /p62
Adipo WAT ( Figures 1E-1H ). The enriched EMT signature was further supported by immunoblotting, which revealed an inverse correlation of E-cadherin (epithelial) and vimentin (mesenchymal) protein levels in PCa tumors ( Figure 4G ). Moreover, the EMT transcriptional drivers (Snail, Slug) were found to be upregulated in TRAMP + /p62 Adipo tumors ( Figure 4H ). Histological analysis of TRAMP tumors demonstrated increased invasion in the surrounding adipose tissue as well adipocytes trapped inside the tumor ( Figure 4I ). Similar results were obtained when orthotopic tumors were analyzed in mice of both genotypes ( Figure 4J ). This latter system consists in the orthotopic growth of syngeneic PCa cells into the prostate of either WT or p62 KO mice, as described recently (Valencia et al., 2014) . Interestingly, and in keeping with the upregulation of Cpt1a in the tumors of TRAMP + /p62
Adipo mice, TRAMP orthotopic tumors grown in p62 KO mice also displayed higher levels of Cpt1a transcripts and protein levels (Figures 4K and 4L) . Collectively these results demonstrate that the loss of p62 in the adipose tissue increases PCa cancer aggressiveness and metastasis, which correlates with enhanced invasion and the upregulation of Cpt1a.
Role of Adipocyte-Specific p62 Deficiency in Tumor Growth and Invasion
To study in more detail the mechanisms whereby adipocyte's p62 controls the metabolic and cellular crosstalk between PCa tumors and the adipose tissue in vivo, we carried out a series of in vitro studies using organotypic cultures. This is a 3D in vitro system that recapitulates the tumor microenvironment (Valencia et al., 2014) . We have successfully set up 3D cultures with adipocytes that maintain the unilocular structure and active functions of adipocytes in vitro ( Figure 5A ). We initially cultured minced adipose tissue from WT or p62 KO mice embedded in the collagen I/Matrigel matrix combined with PCa cells seeded on top of the gel, and evaluated the impact of p62-deficient adipose tissue explants on prostate cell invasion. The ability of p62-deficient WAT to promote PCa invasion was significantly larger than that of WT WAT ( Figures 5B and 5C ). We then separated mature adipocytes and stromal vascular fraction (SVF) containing preadipocytes, endothelial cells, macrophages, and adipocyte stem cells, and tested them in organotypic cultures. Interestingly, mature adipocytes, as well as the whole SVF from p62 KO mice, produced a marked increase in PCa invasion ( Figures 5D-5G ), whereas macrophages had no effect (Valencia et al., 2014) . Two-chamber co-culture studies, as described in Figure 5H , showed that exposure of TRAMP-C2RE3 and Myc-CAP cells to conditioned medium (CM) from p62 KO WAT pro- Figure 6C ). Further analysis showed higher expression of M2 markers such as Arg1 and Mgl2 ( Figure 6D ), indicating an enrichment toward the M2 lineage. Importantly, there was a dramatic upregulation in the levels of Spp1 (coding osteopontin [OPN]) (Figure 6D) . This is of particular relevance, since high levels of OPN expression in M2-polarized macrophages are essential for the remodeling of the adipogenic cell niche and for tumorigenesis (Ahmed et al., 2016) . Therefore, we next compared the adipose tissue secretomes of TRAMP + / p62
Adipo and TRAMP + /WT mice. Interestingly, the most highly expressed transcript corresponding to a secreted protein was Spp1 ( Figures 6E and S5A ). Consistent with this, serum levels of OPN were increased in TRAMP + /p62 Adipo mice compared with WT controls ( Figure 6F ). Notably, OPN expression was also upregulated in the adipose tissue of tumor-free p62 Adipo mice ( Figures 6G and 6H ). This indicates that p62 deficiency in the adipose tissue results in OPN expression that is further amplified by the TRAMP tumor. The similarity in the expression pattern of OPN ( Figure 6H ) and F4/80 ( Figure 6A ) suggests a strong association between OPN overexpression and macrophage infiltration in WAT. Interestingly, immunofluorescence analysis of the adipose tissue revealed that OPN was not only Table S1 . expressed in the CLS niche (identified by F4/80) in p62
Adipo WAT, but also in adipocytes that were not located in CLS, whereas OPN was almost undetectable in WT WAT ( Figure 6I ). Spp1 mRNA levels were also increased in primary adipocytes but not in macrophages both isolated from eWAT of p62 Adipo mice ( Figure S5B ). Furthermore, OPN protein levels were also increased in SVF-differentiated p62 KO adipocytes ( Figure S5C ), suggesting that OPN derived from adipocytes is the primary driver of the phenotype. Analysis of tumors from TRAMP + / p62
Adipo mice showed enhanced expression of Spp1 transcripts ( Figure 6J ). Furthermore, GSEA of the TRAMP + /p62 Adipo PCa transcriptome revealed an enrichment in the PRAD_SPP1 signature compared with TRAMP + /WT tumors ( Figure 6K ). This signature was created with the top SPP1 most correlated genes from the TCGA_PRAD dataset, further demonstrating the human relevance of the increased OPN levels in the Adipo mice have higher levels of Synaptophysin (Syp) and Enolase 2 (Eno2), two well-established neuroendocrine markers ( Figure 6L ). Of note, Spp1 mRNA levels positively correlated with the expression of Syp and Eno2 in TRAMP tumors ( Figure 6M ). Consistent with this result, and of human relevance, the levels of OPN were also increased when neuroendocrine tumors were compared with adenocarcinoma in human PCa samples ( Figure 6N ) (Beltran et al., 2011) . Altogether these results support a role for OPN in mediating tumor aggressiveness driven by adipocyte p62 deficiency.
Osteopontin Promotes Tumor Invasion and Migration through CPT1A Since p62 deficiency in adipocytes promotes the upregulation of CPT1A in TRAMP tumors, we next determined its potential role in PCa cell migration, invasion, and proliferation. To this end, we generated Myc-CAP and TRAMP-C2RE3 PCa cells deficient in CPT1A by using short hairpin RNA (shRNA) vectors. Boyden chamber Transwell studies demonstrated that CPT1A deficiency diminished the invasive capacity of two different types of PCa cells ( Figures 7A and S6A) . Moreover, PCa cell proliferation was also hampered by CPT1A deficiency ( Figure S6B ). Organotypic studies co-culturing minced adipose tissue from WT or p62 Adipo mice with CPT1A-proficient or -deficient Myc-CAP PCa cells demonstrated that the ability of p62 Adipo WAT to promote the invasion of Myc-Cap cells was severely inhibited by CPT1A deficiency ( Figure 7B) . Interestingly, PCa cell invasion stimulated by CM from p62-deficient but not from WT WAT was also abrogated by CPT1A inactivation either by shRNA (Figure 7C ) or the addition of the CPT1 chemical inhibitor, etomoxir ( Figure 7D ). Since the adipocyte-specific deletion of p62 results in upregulated Spp1 also in PCa tumors ( Figure 6K ), we next determined whether OPN is sufficient to promote PCa cell migration and invasion and whether that requires CPT1. Interestingly, exposure of Myc-CAP and TRAMP-C2RE3 cells to OPN was sufficient to promote their migration and invasion, which were totally abrogated by CPT1A deficiency ( Figures 7E, 7F, S6C , and S6D). We also found that incubation of Myc-CAP PCa cells with OPN was sufficient to drive cell proliferation, which was abolished by CPT1A deficiency ( Figure S6E ). We next determined whether OPN could upregulate CPT1 expression, and whether this resulted in increased FA oxidation (FAO) in PCa cells. Notably, CPT1A protein levels in Myc-CAP cells were significantly elevated upon OPN treatment ( Figure 7G ). Importantly, in vitro culture of TRAMP + prostate organoids with OPN resulted in enhanced OCR ( Figure 7H ). This effect was abrogated by treatment with etomoxir, demonstrating the contribution of FAO to the OPN-enhanced OCR ( Figure 7H ). Of note, the transcript levels of Cpt1a, and its upstream regulator Ppara, were upregulated by OPN in organoids ( Figure 7I) . Importantly, bioinformatics analysis in different human PCa datasets showed that the levels of SPP1 transcripts and those of two CPT1 isoforms (CPT1A, CPT1B), as well as of another FAO gene, ACAD9, were concomitantly elevated in prostate cancer, showing the highest levels in metastases ( Figures 7J,  S6F , and S6G). Further data mining revealed significant positive correlations of SPP1 with CPT1B and ACAD9 transcripts in several human PCa datasets, including a cohort of human castration-resistant PCa patients (Beltran et al., 2016) (Figures  7K, S6H, and S6I ). Interrogation of a large TCGA cohort of prostate adenocarcinoma patients demonstrated the significant positive correlation between Gleason score and the expression of SPP1, CPT1A, and ACAD9 ( Figures 7L and S6J ). We next analyzed the biochemical recurrence in these patients, which were categorized into four groups based on the co-expression of SPP1 and two CPT1 isoforms, as well as of ACAD9. Of clinical significance, the prognostic outcome was the worst in patients with the highest expression of both SPP1 together with either CPT1 or ACAD9 (Figures 7M and S6K) . Collectively, these results demonstrate that p62 deficiency in the adipose tissue systemically upregulates the expression of OPN, which is critical for PCa proliferation, migration, and invasion, through a Cpt1a-dependent mechanism.
DISCUSSION
Epidemiological data and studies in mice are progressively establishing the importance of obesity in cancer. Although the contribution of exacerbated food intake to the metabolic syndrome and its role in cancer incidence and progression is evident, the molecular underpinnings of how whole metabolism and obesity affect tumorigenesis still need to be fully understood. A common confounding factor in this type of research is that most of these studies involve feeding mice with high-fat diets. Here we profited from a previous mouse model system developed in our laboratory in which the selective genetic inactivation of p62 in the adipose tissue results in increased adiposity and obesity in a manner that is independent of food intake or locomotor activity (Muller et al., 2013) . In this system, we can interrogate how the adipose tissue modulates tumorigenesis and how tumors affect fat tissues, independently of dietary conditions. Using our model, we found that the specific genetic inactivation of p62 in adipocytes promotes a more aggressive phenotype in tumor-bearing mice. Furthermore, we demonstrate /WT mice (n = 3). Organoids were treated with OPN (3 mg/mL) for 5 days before measurement. In the Eto group, etomoxir was injected at port C to block FA oxidation. Right: quantification of maximal respiration rate.
(I) qPCR analysis of Cpt1a and Ppara mRNA expression in OPN-treated organoids as described in (H) (n = 3).
(legend continued on next page) that this correlates with the activation of gene expression networks in the tumor consistent with EMT, which explains the more metastatic and invasive behavior of tumors in TRAMP + / p62 Adipo mice. Notably, the more aggressive phenotype of tumors from TRAMP + /p62 Adipo mice correlated with the enhanced expression of a series of metabolic genes consistent with a higher lipid metabolism and increased FAO, including Cpt1a. This is very important because FAO is considered the dominant bioenergetics pathway in non-glycolytic tumors such as PCa (Liu, 2006) . This metabolic reprogramming orchestrated by the loss of p62 in adipocytes would serve to help the tumor cope with the high energy demand of a more aggressive cancer. Previous reports showed that FAs were provided by proximal adipose tissue for the growth of ovarian cancer cells (Nieman et al., 2011) . This adipocyte-tumor connection is complemented by a reverse link whereby tumors also affect the metabolic state of adipocytes. In this regard, the loss of adipocyte's p62 also favors tumorigenesis by preventing the activation by the tumor of the expression of genes critical for FA anabolism in the adipose tissue. Therefore, we unveil a p62-repressed mechanism for the adipose tissue to contribute to tumor growth by reducing the accumulation of energy in the fat reservoir, making it available for its utilization by the tumor in the form of FAs that will be burned by cancer cells. Furthermore, we also demonstrate that p62 in adipocytes is required for the ability of PCa to upregulate gene expression networks of mitochondrial biogenesis in the adipose tissue. In this way, tumor actions that result in enhanced nutrient utilization and energy wasting in the adipose tissue were abolished in the absence of p62, favoring the utilization of energy by the tumor. Many studies demonstrated that mTORC1 signaling is central to the maintenance of white adipose tissue function due to its essential role in adipogenesis (Cai et al., 2016) . Interestingly, and in agreement with our previously reported data demonstrating a critical role of p62 in mTORC1 activation by nutrients (Duran et al., 2011; Linares et al., 2015) , we show here that the p62-deficient adipose tissue displayed reduced mTORC1 activity. Therefore, p62's role in the metabolism of a tumor-bearing organism is to maintain the activity of adipocyte's mTORC1. This is very important because fat is the key reservoir of body energy. Therefore, although the tumor promotes the metabolic activation of the adipose tissue, which paradoxically would result in fewer nutrients available for its own growth, p62 deficiency (likely by reducing mTORC1 activity in adipocytes) favors the organism response to reduce energy utilization in the fat, favoring the access of PCa tumors to FA to fulfill the tumor's energetic needs through the upregulation of CPT1 and the subsequent increase in FAO. Based on these observations, we can predict that a potential side effect of mTORC1 inhibitors in cancer therapy will be the potentiation of the tumor effects on the metabolic shutdown of the adipose tissue, which undoubtedly will favor tumor metabolism and growth. Our results must also be put in the context of what is already known regarding the communication between tumor and the adipose tissue. It is very well established that certain cancers promote the activation of a metabolic program driven by the ''browning'' of WAT (Kir and Spiegelman, 2016; Petruzzelli et al., 2014) . This phenomenon of fat cachexia results in enhanced fat energy burning, which leads to tissue wasting, similarly to what takes place during muscle cachexia. In the case of fat cachexia, the gain for the tumor is not totally apparent since uncoupled mitochondrial activation in adipocytes by the tumor results in wasting of energy that the tumor desperately needs to proliferate. Our data are of great relevance because we demonstrate that the loss of p62 in adipocytes severely inhibits WAT browning by the tumor, unveiling the existence of a previously unappreciated and completely different mechanism of p62-controlled fat-tumor communication. Thus, instead of activating adipose energy expenditure as occurs during browning cachexia, the tumor and the adipose tissue establish a symbiotic interaction whereby the low energy utilization of the adipose tissue in the absence of p62 helps the high energetic demands of the tumor. These data are consistent with the general concept that has emerged recently whereby although p62 might function as a tumor promoter in the cancer epithelium, it plays a non-cell-autonomous role as tumor suppressor in the microenvironment (Moscat et al., 2016; Reina-Campos et al., 2017) .
Another critical question arising from the studies reported here is the nature of the signal generated by the loss of p62 in adipocytes that makes PCa tumors more aggressive and more metabolically active through the upregulation of Cpt1a and FAO. Our results demonstrate that OPN plays a central role in this process, which is consistent with other studies suggesting the implication of this multifunctional molecule in inflammation, cell migration, and tissue remodeling, contributing to a variety of cancers including PCa (Rangaswami et al., 2006) . Thus, elevated OPN levels in patients' tumor tissue and blood were correlated with metastatic potential and poor prognosis (Shevde et al., 2010) . OPN can be expressed by both tumor cells and cellular components of the tumor microenvironment, such as macrophages (Ahmed et al., 2016; Lee et al., 2013) . In this regard, our data integrate previously reported roles for OPN in cancer by unveiling a molecular link between adipose tissue and tumor epithelium through the control of cancer metabolism in a (J) Box-and-whisker plots of CPT1A and 1B transcript levels in prostate samples from different lesion sites in human prostate cancer dataset (Grossa 2012) extracted from Oncomine. Median (horizontal line), interquartile range (box), and 10 th -90 th percentiles (whiskers). Mann-Whitney test.
(K) Scatterplots of expression of SPP1 related to CPT1B in patient samples (n = 93) from dataset described in ( Results are presented as mean ± SEM except (A) to (I). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Student's t test unless indicated otherwise. See also Figure S6 .
non-cell-autonomous and p62-dependent manner. We establish here that although the expression of OPN is enhanced not only in adipocytes of TRAMP + /p62 Adipo mice but also in macrophages and tumors, the initiating event is the selective loss of p62 in adipocytes since the levels of p62 in macrophages and tumors are not reduced. Therefore, an interesting question for future studies is how p62 deficiency in adipocytes triggers the synthesis of OPN. However, irrespective of that mechanism, what is important is that we demonstrate here that OPN is a central link between the pro-tumorigenic adipose tissue and the cancer cell through the upregulation of CPT1 and the generation of the energy required for the tumor to acquire a more invasive and metastatic phenotype. These findings are of clinical relevance since the analysis of the human castration-resistant PCa dataset demonstrates a significant correlation between OPN transcripts and those of Cpt1, which also positively correlated with Gleason score and metastasis in human PCa. In summary, our model ( Figure 7N ) proposes a systemic communication between PCa tumors and fat, resulting in antithetic metabolic reprogramming in both tissues, which ultimately results in increased tumor malignancy.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse Models WT and p62KO mice were previously described (Duran et al., 2004) . p62 f/f Ap2-Cre mice were previously described (Muller et al., 2013) . TRAMP + mice were previously described (Greenberg et al., 1995) . All mouse strains were generated in a C57BL/6 background.
All mice were born and maintained under pathogen-free conditions. All genotyping was done by PCR. Male mice were sacrificed and adipose tissues and genitourinary (GU) sections were dissected. Animal handling and experimental procedures were approved by the Institutional Animal Care and Use Committee at SBP Medical Discovery Institute.
Cell Lines
PCa cells (TRAMP-C2RE3 and Myc-CAP) are cultured in DMEM supplemented with 10% FBS. Knock down of CPT1A in PCa cells was achieved by mammalian Lentiviral shRNAs transduction. Briefly, lentiviral shRNA-encoding plasmids were cotransfected with packaging plasmids into actively growing HEK293T cells by using X-tremeGENE transfection reagent. Virus-containing supernatants were collected 48 hours after transfection, filtered to eliminate cells, and then used to infect target cells in the presence of 8 mg/ml polybrene. Cells were selected with puromycin (3 mg/ml). For primary adipocyte and stroma vascular fraction (SVF), epididymal adipose tissue was excised and minced in 10 ml of HBSS solution containing 0.5% BSA-Fatty acid free. Collagenase II (0.5 mg/ml) was added, and the tissue was incubated at 37 C with shaking (30 min). A total of 10 mM EDTA was added 5 min before the end of the incubation. Larger particles were removed using a 100 mm cell strainer, and the filtrates were centrifuged at 500 g for 5 min three times to separate floating adipocytes and pelleted stromal vascular fraction (SVF) and remove collagenase residue. SVF were suspended in erythrocyte lysis buffer (155 mM NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA) and incubated at room temperature for 5 min to deplete erythrocytes. Adipocytes and SVF were collected and suspended in DMEM/F12 containing 10% FBS for experiments. Enrichment of F4/80 + cells (macrophages) in SVF was performed by magnetic immunoaffinity with APC conjugated F4/80 antibody and APC positive selection kit. For adipocyte differentiation, SVF were isolated from inguinal adipose tissue as mentioned above. Isolated SVF were seeded in culture dish for 2 days to eliminate the unattached dead cell/white blood cell populations. SVF including adipogenic precursors were passed into 6-well plate for in vitro differentiation. Two days post confluence, differentiation was initiated by induction cocktail (DMEM/F12 containing 1mM Dexamethasone, 10mg/ml Insulin, 0.5mM IBMX and 10mM Rosiglitazone and 10% FBS) for 3 days, followed by maintenance cocktail (DMEM/F12 containing 10mg/ml Insulin and 10% FBS) for another 4 days. Media were then changed to normal growth media till the endpoint of experiments. All cells are incubated at 37 C, 5% CO 2 atmosphere. For prostate organoids, murine prostates were enzymatically digested with collagenase type II and subsequently with TrypLE. Cells were seeded in growth factor reduced Matrigel and overlaid with advanced DMEM/F12 medium containing: Glutamax, Hepes, Normocin, 1x B27, 1x N2, 50 ng/ml EGF, 500 ng/ml recombinant R-spondin1, 100 ng/ml recombinant Noggin, 200 nM TGF-b/Alk inhibitor and 1 nM Dihydrotestosterone.
METHOD DETAILS
Indirect Calorimetry
Food intake, drinking, heat production, energy expenditure, respiratory exchange ratio, and home-cage activity were assessed in male mice of 7-month-old using an automated indirect calorimetry Oxymax system of the Comprehensive Lab Animal Monitoring System (CLAMS; Columbus Instruments) at UCSD Animal Care Program. After 24 hr of adaptation, O 2 consumption and CO 2 production were measured every 13 min for a total of up to 72 hr to determine the respiratory quotient and energy expenditure. Food intake was determined continuously for the same time as the indirect calorimetry assessments by integration of scales into the sealed cage environment. Home-cage locomotor activity was determined using a multidimensional infrared light beam system with beams scanning the bottom and top levels of the cage, and activity being expressed as beam breaks.
Body Composition Measurements
Whole-body composition (fat and lean mass) in male mice of 7-month-old was measured using Dual-Energy X-ray Absorptiometry (DXA) at UCSD Animal Care Program.
Immunoblot Analysis
Protein extracts were separated by SDS-PAGE and transferred to Immobilon-P PVDF membranes (Millipore). After blocking with 5% nonfat dry milk in Tris-buffered saline and 0.1% Tween (TBS-T), the membranes were incubated with the indicated antibodies overnight at 4 C. After 2 hr incubation with the appropriate horseradish peroxidase-conjugated antibodies, the immune complexes were detected by chemiluminescence (Thermo Scientific).
Histological Analysis
Tissues from indicated male mice were isolated, rinsed in ice-cold PBS, fixed in 10% neutral buffered formalin for 24 h, dehydrated, and embedded in paraffin. Livers were embedded in Tissue Tek O.C.T. compound and snap frozen in dry ice, then kept in -80 C. Tissue sections (5 mm) were stained with hematoxylin and eosin (H&E). Pathological characterization of cancer sample degree was assessed using the reported criteria (Ittmann et al., 2013) in a blinded fashion by a pathologist. Histological sections of epidydimal fat pads were stained with H&E and studied under 20-fold magnification to compare adipocyte size. At least seven fields per section from four different mice of each genotype were randomly selected to determine the adipocyte size and number according to morphological feature using ''ImageJ''-based software ''Adiposoft''. Frozen liver sections (5 mm) were stained with Oil red O (SigmaAldrich) to detect lipid accumulation. Sections were fixed in paraformaldehyde and stained for 3 h in 0.5% Oil red O in propylene glycol, followed by 1 min incubations in 85% aqueous propylene glycol. After the slides were washed in distilled water, they were counterstained with Harris's hematoxylin for 10s. For immunohistochemical (IHC) detection, sections were deparaffinized, rehydrated, and treated for antigen retrieval. After blocking with Avidin/Biotin blocking kit or M.O.M. Ig Blocking Reagent, tissues were incubated with primary antibody overnight at 4 C (OPN) or 30 min at room temperature (F4/80) followed by incubation with biotinylated secondary antibody. Endogenous peroxidase was quenched in 3% H 2 O 2 in water for 10 min at room temperature. Antibodies were visualized with avidin/biotin complex Vectastain Elite using diaminobenzidine as the chromagen. For immunofluorescence, sections were incubated with Alexa-conjugated secondary antibodies (Life Technologies) and the samples examined with a Zeiss LSM 710 NLO Confocal Microscope.
Lipid Analysis
Plasma/tissue triglyceride and total cholesterol were determined spectrophotometrically (Wako Diagnostics, USA). For determination of lipids mass, liver sample were washed with PBS and frozen. Total lipids were isolated from homogenates by Folch extraction. Briefly, around 100 mg tissue samples were homogenized in 1 mL methanol, homogenates were further mixed with 2 ml chloroform and rotated mildly for 2 hr to extract lipid. Samples were then mixed roughly with 1 ml H 2 O for 30 s to separate phases. The lipidcontaining organic phase (bottom) were collected and dried by nitrogen. Total lipids were dissolved in PBS containing 1% Triton-X 100, followed by quantification by kits. The tissue lipid concentrations were normalized to tissue protein mass.
Adipose Tissue Conditioned Media 1g epididymal adipose tissue were minced thoroughly and incubated in 4 ml serum-free DMEM containing 1% BSA-Fatty acid free for 24 h. Conditioned media were aliquoted and frozen in -80 C until use.
Migration and Invasion Assay
Wildtype, shNT and shCPT1A PCa cells (TRAMP-C2RE3 and Myc-CAP) were assayed for their ability to migrate or invade through a polyethylene terephthalate membrane inserts in 24-well format using Corning BioCoatÔ Insert System (Corning). A total of 2.5 310 4 cells/well were seeded into the inner chamber in serum-free DMEM, and cells were challenged with OPN (5 mg/ml in 0.2% FBS containing DMEM) or conditioned media of epidydimal WAT (WT and p62 KO mice) in the outer chamber. After indicated incubation at 37 C, 5% CO 2 , cells that migrated/invaded through the pores onto the bottom of the insert were fixed in 100% methanol and stained with crystal violet. The total number of migrating/invading cells was determined by counting the cells on the lower surface of the insert using a light microscope at 20x magnification.
RNA Analysis
Total RNA from mouse tissues and cultured cells was isolated using the TRIZOL reagent (Invitrogen) and the RNeasy Mini Kit (QIAGEN), followed by DNase treatment. After quantification using a Nanodrop 1000 spectrophotometer (Thermo Scientific), RNA was reverse-transcribed using random primers and MultiScribe Reverse Transcriptase (Applied Biosystems). Gene expression was analyzed by amplifying 20 ng of the complementary DNA using the CFX96 Real Time PCR Detection System with SYBR Green Master Mix (BioRad) and primers described in Table S2 . The amplification parameters were set at 95 C for 30 s, 58 C for 30 s, and 72 C for 30 s (40 cycles total). Gene expression values for each sample were normalized to the 18S RNA.
Organotypic Cultures 3D air liquid organotypic culture set up as previously described (Valencia et al., 2014) , has been used to determine the mechanisms of prostate cancer cell invasion and the role of the adipose tissue compartments on cancer cell invasion. Briefly, gels were composed of 1.75 volumes of Matrigel, 5.25 volumes of collagen type I, 1 volume of 1x DMEM, 1 volume of 10x DMEM, and 1 volume of filtered FBS. 0.9 ml gels were then mixed with 0.1 ml cell suspension containing 300,000 adipocytes, 1,000,000 SVF cells or 40 mg minced WAT. The cell-gel/tissue-gel mixture was plated onto 24-well plates coated with diluted collagen type I. Gels were equilibrated with 1 ml of 1x DMEM overnight at 37 C. 5 x 10 5 cells PCa cells were then seeded on top of the matrix. Gel rafts were placed onto collagencoated nylon sheets and lifted using a sterile supporting steel mesh to set up a raised air-liquid culture. Normal medium was changed in alternate days and organotypic cultures were maintained to grow for 14 days. Afterwards, organotypic gels were harvested, fixed in 10% neutral buffered formalin, bisected and embedded in paraffin. H&E stained sections were analyzed with a Zeiss light microscope supplemented with Axiovision40 software. Quantification of the invasion assays was performed using ImageProPlus software.
Respiration Assays
The cellular oxygen consumption rate (OCR) of primary adipocytes was determined using an XFp Extracellular Flux Analyzer (Seahorse Bioscience). Prior to assay, 10,000 WT and p62 KO SVF cells were seeded into XFp microplates. One day later, Adipogenic differentiation was initiated using a protocol mentioned above. Seven days post differentiation, adipocyte culture medium was changed to XF basal medium containing 10 mM glucose, and 1 mM pyruvate. The uncoupled and maximal OCRs were determined using 1 mM oligomycin and 1 mM FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone), respectively. Complex-I-dependent respiration was inhibited with a mix of antimycin A and rotenone, 2 mM each. Oxygen consumption values were normalized to protein content. OCR of intact adipose tissue explants was measured using a XF24 Extracellular Flux Analyzer (Seahorse Bioscience). Briefly, freshly isolated inguinal adipose tissues were harvested from 7-month-old mice and was rinsed with unbuffered DMEM (pH 7.4). The adipose tissue was cut into sections using a 2mm biopsy punch, and 2 punches were placed in each well of an XF24 Islet Capture Microplate (Seahorse Bioscience). The tissue was then covered with a screen, which allowed free perfusion while minimizing tissue movement. XF basal medium supplemented with 10 mM glucose and 1 mM pyruvate was then added to each well. At least 4 to 6 replicates from each animal were used for the assay. The plate was incubated at 37 C in a non-CO2 incubator for 30 minutes before extracellular flux analysis. After five baseline measurements, OCR was measured after the addition of the following drugs: 10 mM oligomycin, 20 mM FCCP, and 12 mM rotenone + 12 mM antimycin A as indicated. Oxygen consumption values were normalized to protein content. The oxygen consumption rate of prostate organoids was measured using a XF24 Extracellular Flux Analyzer (Seahorse Bioscience). Organoids were prepared from prostates of 2-month-old TRAMP + hemizygous mice and treated with 3 mg/ml OPN for 5 days, starting 2 days after seeding. OPN was refreshed every two days. After 5 days of OPN treatment, organoids were harvested using cold PBS and seeded in XF medium with 10 mM glucose, 0.5 mM carnitine and 5 mM Hepes on top of a matrigel-precoated XF24 microplate. The plate was centrifuged at 600g for 5 min, and then incubated at 37 C in a non-CO2 incubator for 30 minutes before extracellular flux analysis. After five baseline measurements, OCR was measured after the addition of the following drugs: 15 mM oligomycin, 20 mM fluoro-carbonyl cyanide phenylhydrazone (FCCP), 200 mM etomoxir, and 12 mM rotenone + 12 mM antimycin A, as indicated.
RNAseq, Gene Set Enrichment Analysis, CIBERSORT and Secretome Analysis
The gene matrix files of adipose tissues and prostate tumors of TRAMP + /p62 Adipo and TRAMP + /WT mice were generated with
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using GraphPad Prism 7. Unpaired Student's two-tailed t test and nonparametric Mann-Whitney test were used to determine significance of differences between groups where appropriate. Correlation was studied by Pearson's correlation test as indicated. Differences in Kaplan Meier plots was analyzed by Log-Rank test. Values of p < 0.05 were considered as significantly different.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is GSE100060. Unprocessed original data have been deposited to Mendeley Data and are available at https://doi.org/10.17632/hzm74h2k3x.1
